Skip to main navigation Skip to search Skip to main content

Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: Results of a multicenter management study

  • Carlos Aguilar
  • , Michelangelo Sartori
  • , Armando D'Angelo
  • , Christopher Kabrhel
  • , James Groce
  • , Emmanuel De Maistre
  • , Suman M. Wasan
  • , Jeannine Kassis
  • , John Lazarchick
  • , Colin Kaide
  • , Pascual Marco Vera
  • , Jeffrey Kline
  • , D. Mark Courtney
  • , Andrew Rubin
  • , Melhem Sharafuddin
  • , Gilles Pernod
  • Hospital General Santa Barbara
  • Ospedaliera Policlinico S. Orsola Malpighi
  • Ospedale San Raffaele
  • Massassuchetts General Hospital
  • Moses H. Cone Memorial HospitalCone HealthGreensboro
  • CHU de Dijon
  • OKC VAMS Pathology and Laboratory Services
  • Hôpital Maisonneuve-Rosemont
  • Medical University of South Carolina
  • Ohio State University Medical Center
  • Hopsital General Universitario de Alicante
  • Indiana University Health
  • Northwestern University
  • Texas Health Fort Worth Hospital
  • University of Iowa Hospitals and Clinics
  • Grenoble-Alpes University Hospital

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)562-566
Number of pages5
JournalBlood Coagulation and Fibrinolysis
Volume29
Issue number6
DOIs
StatePublished - 2018
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • D-dimer
  • Deep venous thrombosis
  • Exclusion
  • STA-Liatest DDi

Cite this